Sign In
Buy KURA
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
Kura Oncology (NASDAQ:KURA) Rating Increased to Buy at Zacks Investment Research
07:04am, Saturday, 29'th Feb 2020
Kura Oncology (NASDAQ:KURA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday, Zacks.com reports
Brokers Issue Forecasts for Kura Oncology Inc's Q1 2020 Earnings (NASDAQ:KURA)
11:26am, Friday, 28'th Feb 2020
Kura Oncology Inc (NASDAQ:KURA) – Stock analysts at Svb Leerink issued their Q1 2020 EPS estimates for Kura Oncology in a research note issued on Wednesday, February 26th. Svb Leerink analyst J. Cha
Kura Oncology (NASDAQ:KURA) Reaches New 52-Week Low on Analyst Downgrade
06:46am, Friday, 28'th Feb 2020
Kura Oncology Inc (NASDAQ:KURA)’s share price reached a new 52-week low on Thursday after Piper Sandler lowered their price target on the stock from to . The stock traded as low as $11.41 and last t
Kura Oncology (KURA) Received its Third Buy in a Row
12:21pm, Wednesday, 26'th Feb 2020
After Cowen & Co. and Oppenheimer gave Kura Oncology (NASDAQ: KURA) a Buy rating last month, the company received another Buy, this time from H.C.
Kura Oncology (KURA) Received its Third Buy in a Row
12:21pm, Wednesday, 26'th Feb 2020
After Cowen & Co. and Oppenheimer gave Kura Oncology (NASDAQ:
KURA
) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst
Joseph Pantginis
reiterated a
Bu
Kura Oncology, Inc. (KURA) Q4 2019 Earnings Call Transcript
06:30am, Wednesday, 26'th Feb 2020
KURA earnings call for the period ending December 31, 2019.
Edited Transcript of KURA earnings conference call or presentation 25-Feb-20 9:30pm GMT
06:08am, Wednesday, 26'th Feb 2020
Q4 2019 Kura Oncology Inc Earnings Call
Kura Oncology (KURA) Gets a Buy Rating from Cowen & Co.
04:06am, Wednesday, 26'th Feb 2020
Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Kura Oncology (KURA) yesterday. The company's shares closed last Monday at $12.46,
Kura Oncology (KURA) Gets a Buy Rating from Cowen & Co.
04:06am, Wednesday, 26'th Feb 2020
Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Kura Oncology (KURA – Research Report) yesterday. The company’s
Oppenheimer Maintains Their Buy Rating on Kura Oncology (KURA)
04:06am, Wednesday, 26'th Feb 2020
In a report released yesterday, Jay Olson from Oppenheimer maintained a Buy rating on Kura Oncology (KURA), with a price target of $27.00. The company's
Oppenheimer Maintains Their Buy Rating on Kura Oncology (KURA)
04:06am, Wednesday, 26'th Feb 2020
In a report released yesterday,
Jay Olson
from Oppenheimer maintained a
Buy
rating on Kura Oncology (
KURA
–
Research Report
), with a price target of
$27.00
. The company’s shares closed last Mon
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q4 2019 Results - Earnings Call Transcript
01:01am, Wednesday, 26'th Feb 2020
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2019 Earnings Conference Call February 25, 2020 4:30 p.m. ET Company Participants Pete De Spain - VP, IR Troy Wilson - Pres
Kura Oncology: 4Q Earnings Snapshot
09:51pm, Tuesday, 25'th Feb 2020
SAN DIEGO (AP) _ Kura Oncology Inc. (KURA) on Tuesday reported a loss of $17.9 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a loss of 39 cents. The resu
Kura Oncology: 4Q Earnings Snapshot
09:50pm, Tuesday, 25'th Feb 2020
SAN DIEGO (AP) _ Kura Oncology Inc. (KURA) on Tuesday reported a loss of $17.9 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 39 cents.
The resu
Kura Oncology Reports Fourth Quarter and Full Year 2019 Financial Results | MarketScreener
09:04pm, Tuesday, 25'th Feb 2020
– Registration-directed trial of tipifarnib in HRAS mutant head and neck squamous cell carcinomas anticipated to complete enrollment in first quarter of 2021 – – Company… | February 25, 2020
